Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine XR versus mirtazapine in acute stress disorder
2007-000088-12Phase 3Completed
- Sponsor
- Department of Psychiatry, LMU Munich
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of quetiapine in acute stress disorder (ASD) (2 arms), sponsored by Department of Psychiatry, LMU Munich. Primary endpoint: Clinical efficacy on key ASD symptoms. Started Aug 2009; status: completed.
02
Drugs
quetiapine
03
Conditions
acute stress disorder (ASD)
Beyond the preview
Go deeper on 2007-000088-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000088-12.